Using wearable data to predict heart health and cardiovascular risk
Assessment and Prediction of Cardiovascular Health and Disease Risk Using Longitudinal Wearable Biometrics: a Prospective Cohort Study.
This will test whether continuous Fitbit data can help track and predict heart health and future cardiovascular risk in adults.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University College Dublin Academic / other |
| Locations | 1 site (Dublin, Dublin) |
| Trial ID | NCT07401550 on ClinicalTrials.gov |
What this trial studies
This observational cohort will provide participants with a Fitbit Charge 6 to wear continuously for six months, with device data collected via Fitabase. Clinical cardiovascular assessments and calculation of the American Heart Association Life's Essential 8 score will be performed at baseline, three months, and six months. Participants will complete weekly and monthly patient-reported outcome surveys on symptoms, sleep, mood, alcohol use, and activity. Analyses will examine whether wearable-derived biometrics, alone or combined with point-of-care measures, correlate with and predict changes in cardiovascular health and risk factors.
Who should consider this trial
Good fit: Adults aged 18 and older who can attend three clinic visits at Beacon Hospital in Dublin, have internet access, and own a smartphone compatible with the Fitbit app are ideal candidates.
Not a fit: People who are pregnant, have unstable medical conditions or cognitive impairments that prevent following the protocol, or who cannot wear a wrist device (for medical or skin reasons) may not benefit or be eligible.
Why it matters
Potential benefit: If successful, wearables could offer low-burden, continuous monitoring to detect worsening cardiovascular health earlier and support more personalized prevention.
How similar studies have performed: Prior studies have shown promising links between wearable metrics (activity, heart rate, sleep) and individual cardiovascular outcomes, but applying wearables to predict composite Life's Essential 8 scores is relatively new.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years, or older * Internet access * Possession of a smartphone compatible with the Fitbit mobile app Exclusion Criteria: * Pregnancy * Unstable medical condition * Inability to provide informed consent * Mental or cognitive impairment precluding adherence to study protocol * Smartwatch cannot be worn, (e.g., allergic reactions), or cannot be worn in accordance with manufacturer guidelines (e.g., amputation, dark tattoos at wrist)
Where this trial is running
Dublin, Dublin
- Beacon Hospital — Dublin, Dublin, Ireland (Recruiting)
Study contacts
- Principal investigator: Rory Lambe — University College Dublin
- Study coordinator: Rory Lambe
- Email: rory.lambe@ucdconnect.ie
- Phone: +353 1 716 3442
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.